Frésard, I., P. Bridevaux, and J. Janssens. “Adverse Effects and Adherence to Treatment of Rifampicin 4 months Vs Isoniazid 6 months for Latent Tuberculosis”. Swiss Medical Weekly, vol. 141, no. 3334, Aug. 2011, p. w13240, doi:10.4414/smw.2011.13240.